Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, ...

Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, Minnesota, confirmed that ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

Ireland: Medtronic plc has announced its intent to separate its Diabetes business into a new standalone company.The ...

Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...

The new diabetes company will be predominantly business-to-consumer, while Medtronic’s model was more business-to-business.